PharmaTelevision - Fountain Medical Development: Clinical trials, government involvement and China's future

PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Fountain Medical Development: Clinical trials, government involvement and China's future

Visitors: You are watching a 5 minute preview.

Get more information and subscribe now

RSS

Twitter

In This Episode:

Summary
Transcript
Participants
Company

In this interview, filmed at BioPharm in San Francisco, Dr Fintan Walton speaks with Joanne Jiang, Executive Vice President at Fountain Medical Development, a new contract research organisation in China

They discuss:

• the nature of FMD's work in clinical trials
• assisting clients with drug development
• clinical trials inside and outside China
• how FMD's government grant allows them to use hospital space for research
• China's role in clinical trials over the next 3-5 years, and how business is done differently
• Working with experienced and less experienced partners
• MNAs, CROs and innovation as part of China's future

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

The nature of FMD's work in clinical trials.

Fintan Walton:

Hello and welcome to PharmaTelevision News Review here in San Francisco at BioPharm America. On this show, I have Joanne Jiang, who is the Vice President at Fountain Medical Development, Welcome.

Joanne Jiang:

Thank you.

Fintan Walton:

Joanne, Fountain Medical Development is a company that is operates within China and around the Asia region including places like Taiwan and Korea. What exactly is Fountain Medical Development?

Joanne Jiang:

Well we are a company that have been founded two-years ago by a group of attorneys from US originally from China, but studied and trained and worked in large CRO's and pharma in US and they returned China, established a contract research organization which is Fountain. And we conduct clinical trials for biotech and pharmaceutical companies. And our main clients come from US, Europe and other regions of the world. And we conduct these trials in hospitals in China, Hong Kong, Korea and Taiwan for these clients.

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

Joanne Jiang

Executive Vice President

Dr Jiang has been working in the pharmaceutical industry for 14 years. She started her career in preclinical pharmacology area at Bayer pharmaceutical and Eli Lilly, working as research scientist, lab head and project leader. She further developed expertise in drug development and project management through her tenure as global project manager since year 2000. From year 2000 to 2007, at Aventis and then Daiichi Sankyo, she managed drug development and life cycle management projects, encompassing preclinical to phase IV activities. She especially focused on clinical trial planning and management, integrating marketing plans and regulatory strategy that enables optimal trial design. Effective implementation of the clinical studies delivered best data quality and timeline. Dr. Jiang also has working knowledge of building and managing high performing project teams that deliver break-through results. Dr Jiang co-founded Fountain Medical Development, a contract research organization (CRO) offering a full range of ICH GCP compliant clinical research services for multinational clients conducting clinical research in Asia.Dr. Jiang holds a PhD in pharmacology and toxicology from Indiana University and an MBA from University of Michigan, Dearborn.

Fountain Medical Development

Fountain Medical Development Corp. is a contract research organization (CRO) offering a full range of ICH GCP compliant clinical research services for multinational clients conducting clinical research in China. The management team of Fountain has decades of combined experience working with the world's leading CRO's and drug developers. In the Chinese CRO market, they fill the void of a service provider that balances high quality with moderate cost. Fountain's extensive global experience in multiple therapeutic areas is unmatched by other local CRO's, and lower operational costs allow them to pass significant savings on to its clients